Provided by Tiger Trade Technology Pte. Ltd.

Collegium Pharmaceutical

47.61
+0.69001.47%
Post-market: 47.610.00000.00%18:19 EST
Volume:259.04K
Turnover:12.32M
Market Cap:1.50B
PE:29.29
High:48.05
Open:47.48
Low:47.05
Close:46.92
52wk High:50.79
52wk Low:23.23
Shares:31.61M
Float Shares:28.09M
Volume Ratio:0.76
T/O Rate:0.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.63
EPS(LYR):1.86
ROE:22.96%
ROA:6.75%
PB:5.48
PE(LYR):25.64

Loading ...

Collegium Pharmaceutical management to meet with Truist

TIPRANKS
·
Yesterday

What Collegium Pharmaceutical (COLL)'s Revenue Surge and Low Valuation Means For Shareholders

Simply Wall St.
·
Feb 03

Collegium Pharmaceutical Showcases New Real-World Data on Jornay PM at APSARD 2026

Reuters
·
Jan 15

Does Collegium’s 2026 Revenue Guidance After Insider Sales Change The Bull Case For COLL?

Simply Wall St.
·
Jan 15

Collegium Pharmaceutical price target raised to $60 from $46 at H.C. Wainwright

TIPRANKS
·
Jan 09

Collegium Pharmaceutical Is Maintained at Buy by Needham

Dow Jones
·
Jan 09

Collegium Pharmaceutical (COLL) Receives a Buy from Barclays

TIPRANKS
·
Jan 09

Collegium Pharmaceutical: Strengthened 2026 Outlook, Balance Sheet Flexibility, and BD Upside Support Buy Rating and Higher Target

TIPRANKS
·
Jan 09

BRIEF-Collegium Pharmaceutical Outlook FY Revenue USD 805-825 Million

Reuters
·
Jan 08

Collegium Pharmaceutical Inc: on Track to Achieve Recently Increased Financial Guidance for 2025

THOMSON REUTERS
·
Jan 08

Press Release: Collegium Provides 2026 Financial Guidance and Business Update

Dow Jones
·
Jan 08

Truist Securities Adjusts Price Target on Collegium Pharmaceutical to $55 From $48, Maintains Buy Rating

MT Newswires Live
·
Jan 07

Press Release: Collegium Announces the Closing of $980 Million Syndicated Credit Facility

Dow Jones
·
Dec 30, 2025

Dyne Therapeutics Appoints Vikram Karnani to Board of Directors

Reuters
·
Dec 23, 2025

Collegium Pharmaceutical (COLL): Valuation Check After Strong Revenue Beat and Upgraded Full-Year Performance

Simply Wall St.
·
Dec 16, 2025

EVP & Chief Commercial Officer Scott Dreyer Reports Disposal of Collegium Pharmaceutical Inc. Common Shares

Reuters
·
Dec 11, 2025

Collegium Pharmaceutical Director Rita J. Balice-Gordon Reports Sale of Common Shares

Reuters
·
Dec 10, 2025

Collegium Pharmaceutical Initiated at Overweight by Barclays

Dow Jones
·
Dec 09, 2025

Barclays Initiates Collegium Pharmaceutical at Overweight With $58 Price Target

MT Newswires Live
·
Dec 09, 2025

U.S. RESEARCH ROUNDUP-AstraZeneca, Confluent, Pepsico

Reuters
·
Dec 09, 2025